Avenir Wellness Solutions Inc (AVRW)

[ProfitScout]

We keep getting very positive news indicating the high effectiveness and value of the CURR products over other methods of drug delivery. The new study just announced provides excellent evidence.

About the Study
This open-label, randomized, single-dose, crossover study of 14 healthy adults compared the pharmacokinetics of a commercially available soft gel formulation (liquid encapsulated within a shell) of 25mg CBD to 25mg of CBD delivered via CUREfilm®, CURE’s oral thin film, or OTF, dose form. CUREfilm® OTF resulted in a significantly higher maximum serum concentration (~3x increase in Cmax) and a faster onset/absorption (~3x decrease in Tmax), compared to the reference product. No safety concerns were reported. In both arms of the study, the product was administered orally (PO) and, hence, ingested.

The study included a subjective survey comprising eight questions to aid in the understanding of CUREfilm® OTF as an acceptable dosage form. Results showed that none of the participants felt discomfort, pain, numbness or irritation during administration. 80% indicated “great” palatability, with 90% rating the CUREfilm® OTF experience as very pleasant or neutral.